XML 53 R43.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 11 - Subsequent Events (Details Textual)
Apr. 16, 2016
USD ($)
$ / shares
shares
Apr. 15, 2016
USD ($)
shares
Mar. 02, 2016
USD ($)
shares
Feb. 12, 2016
USD ($)
$ / shares
shares
Protagenic Therapeutics Inc [Member] | Series B Preferred Stock [Member]        
Preferred Stock, Par or Stated Value Per Share | $ / shares       $ 0.000001
Protagenic Therapeutics Inc [Member]        
Business Acquisition, Conversion of Stock, Ratio       1
Business Combination, Stock Warrant Conversion Ratio       1
Series B Preferred Stock [Member] | Reverse Stock Split [Member]        
Stockholders' Equity Note, Stock Split, Conversion Ratio       15,463.7183
Series B Preferred Stock [Member] | Private Placement [Member] | Subsequent Event [Member]        
Stock Issued During Period, Shares, New Issues | shares   420,260    
Series B Preferred Stock [Member] | Private Placement [Member]        
Stock Issued During Period, Shares, New Issues | shares     913,200 2,775,000
Shares Issued, Price Per Share | $ / shares       $ 1.25
Stock Issued During Period, Value, New Issues       $ 3,468,750
Proceeds from Issuance of Convertible Preferred Stock     $ 1,141,500  
Series B Preferred Stock [Member] | Private Placement Offering [Member] | Subsequent Event [Member]        
Stock Issued During Period, Shares, New Issues | shares 4,108,460      
Series B Preferred Stock [Member] | Placement Agent Warrants [Member] | Subsequent Event [Member]        
Preferred Stock, Par or Stated Value Per Share | $ / shares $ 1.25      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares 127,346      
Series B Preferred Stock [Member] | Subsequent Event [Member]        
Proceeds from Issuance of Private Placement   $ 525,325    
Private Placement [Member] | Subsequent Event [Member]        
Proceeds from Issuance of Private Placement $ 4,635,575      
Proceeds From Issuance of Private Placement, Net of Issuance Costs 4,283,438      
Private Placement Offering [Member] | Subsequent Event [Member]        
Stock Issued During Period, Value, Conversion of Convertible Securities 500,000      
Proceeds from Issuance of Private Placement 5,135,575      
Proceeds From Issuance of Private Placement, Net of Issuance Costs 4,783,438      
Placement Agent Warrants [Member] | Subsequent Event [Member]        
Payments for Commissions 159,183      
Cost and Expense Allowance $ 15,000      
Conversion of Outstanding Stockholder Debt [Member] | Chairman and Board Member Garo H. Armen [Member]        
Stock Issued During Period, Value, Conversion of Convertible Securities       350,000
Conversion of Outstanding Stockholder Debt [Member] | Predecessor's Stockholder [Member]        
Stock Issued During Period, Value, Conversion of Convertible Securities       $ 150,000